Latest Content
H1 2024 Immune Tolerance Landscape Review
H1 2024 Bispecific Landscape Review
H1 2024 RNA Landscape Review
Webinars
Novel Drug Conjugates and Clinical Success: An In-Depth Analysis of Emerging ADCs
Beacon TPD: Induced Proximity Landscape Review 2024
Webinar – Exploring Allogeneic Cell Therapies: Pioneering Advantages and Recent Innovations
ADC
H1 2024 ADC Landscape Review
Novel Drug Conjugates and Clinical Success: An In-Depth Analysis of Emerging ADCs
Unlocking the Potential of Bispecific ADCs
Bispecific
H1 2024 Bispecific Landscape Review
Unlocking the Potential of Bispecific ADCs
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Cancer Vaccine
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon Cancer Vaccine: 2024 ASCO Annual Meeting Abstracts
2023 Cancer Vaccine Landscape Review
Cell Therapy
H1 2024 Cell Therapy Landscape Review
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Webinar – Exploring Allogeneic Cell Therapies: Pioneering Advantages and Recent Innovations
Checkpoint
H1 2024 Checkpoint Landscape Review
ASCO 2024: Checkpoint Highlights
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Cytokine
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
ASCO 2024: Cytokine Highlights
Charting the Course: Trends and Challenges in Early-Stage Cytokine-Based Drug Development Commercialization
DDR
The 2024 DDR H1 Landscape Review
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon DDR: ASCO Post-Conference Report 2024
Gene Therapy
H1 2024 Gene Therapy Landscape Review
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
Immune Tolerance
H1 2024 Immune Tolerance Landscape Review
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon Immune Tolerance: 2024 EULAR Annual Meeting Abstracts
Microbiome
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Microbiome: US Market and LBP Development
Microbiome: Drug Development in Asia Infographic
Oncolytic Viruses
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon Oncolytic Viruses: 2024 ASCO Annual Meeting Abstracts
2023 Oncolytic Viruses Landscape Review
RNA
H1 2024 RNA Landscape Review
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Unlock the Future of Advanced Therapies: Insights from the ASGCT 2024 Annual Meeting
TPD
Investment Trends in Early-Stage Biopharma: A Beacon Data Perspective
Beacon TPD: ASCO Post-Conference Report 2024
TPD: AACR Post-Conference Report 2024
About Beacon
See how our clinical trials and drug database solutions in action
We are a clinical trial and pipeline database solution, designed in partnership with pharmaceutical professionals. We track targeted therapies to provide accurate, in-depth and real-time information in the rapidly evolving landscape of drug development.
